Previous clinical research has shown that CRC patients with hyperprolactinemia, or serum concentration of PRL over 20 ng/mL, had worse prognosis and shorter overall survival compared to patients with healthy PRL serum levels [14]. This evidence concerns the gene PRL and colorectal carcinoma.